Article
Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted Therapies
29 Oct 2024
Abstract excerpt
Glioblastoma (GBM) is categorized by the World Health Organization (WHO) as a grade 4 glioma and is a uniformly fatal tumor of the central nervous system. With the discovery of specific gene anomalies, GBM classification has been modified several times to provide better diagnostic and prognostic accuracy. Survival outcomes remain dismal despite the current therapeutic modalities, which include a combination of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
